Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...
The third quarter of 2025 closed amid growing macroeconomic strain, policy unpredictability and renewed investor focus on execution risk. While ...
FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback